Novartis Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 38,947.0 | 36,749.0 | 32,526.0 |
| Cost of Goods Sold | 11,032.0 | 10,299.0 | 8,868.0 |
| Gross Profit | 27,915.0 | 26,450.0 | 23,658.0 |
| Gross Profit Margin | 71.7% | 72.0% | 72.7% |
| SG&A Expense | 19,689.0 | 16,480.0 | 16,378.0 |
| Depreciation & Amortization | -- | 2,026.0 | 1,765.0 |
| Operating Income | 8,226.0 | 7,944.0 | 5,515.0 |
| Operating Margin | 21.1% | 21.6% | 17.0% |
| Nonoperating Income | (502.0) | (1,344.0) | 926.0 |
| Nonoperating Expenses | 237.0 | 266.0 | 294.0 |
| Income Before Taxes | 7,487.0 | 8,301.0 | 6,147.0 |
| Income Taxes | 947.0 | 1,157.0 | 946.0 |
| Net Income After Taxes | 6,540.0 | 7,144.0 | 5,201.0 |
| Continuing Operations | 6,540.0 | 5,150.0 | 5,190.0 |
| Discontinued Operations | 5,428.0 | 114.0 | -- |
| Total Operations | 11,968.0 | 5,264.0 | 5,190.0 |
| Total Net Income | 11,968.0 | 5,264.0 | 5,190.0 |
| Net Profit Margin | 30.7% | 14.3% | 16.0% |
| Diluted EPS from Total Net Income ($) | 5.13 | 2.23 | 2.62 |
| Dividends per Share | 0.93 | 0.75 | 0.75 |





